Evaluation of Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2 for 26 Weeks
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Christelle Haziza, PhD
Philip Morris Products S.A.
Study Chair - Danielle Armas, MD
Celerion Arizona
Principal Investigator - Darrell Herrington, MD
Benchmark
Principal Investigator - David Subich, MD
Compass Research
Principal Investigator - Derek Schroder, MD
PMG Research of Cary
Principal Investigator - George Raad, MD
PMG Research of Charlotte
Principal Investigator - George Stoica, MD
Compass Research
Principal Investigator - Hugh Coleman, MD
Covance
Principal Investigator - Isabel Kuhare-Arcure, MD
Midwest Clinical Research
Principal Investigator - John Rubino, MD
PMG Research of Raleigh
Principal Investigator - Keith Scott, MD
National Clinical Research
Principal Investigator - Kevin Cannon, MD
PMG Research of Wilmington
Principal Investigator - Laurence Chu, MD
Benchmark
Principal Investigator - Leonard Dunn, MD
Clinical Research West Florida
Principal Investigator - Lon Lynn, MD
Clinical Research West Florida
Principal Investigator - Mark Adams, MD
Central Kentucky Research Associate
Principal Investigator - Peter Davidson, MD
Celerion Lincoln
Principal Investigator - Stephanie Powell, MD
PMG Research of Bristol
Principal Investigator - William Seger, MD
Benchmark
Principal Investigator - William Smith, MD
NOCCR
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Celerion Arizona
Tempe, Arizona, United States
- Clinical Research West Florida
Clearwater, Florida, United States
- Covance, Inc
Daytona Beach, Florida, United States
- Compass Research
Orlando, Florida, United States
- Clinical Research West Florida
Tampa, Florida, United States
- Compass Research
The Villages, Florida, United States
- Central Kentucky Research Associate
Lexington, Kentucky, United States
- Celerion Lincoln
Lincoln, Nebraska, United States
- Pmg Research of Cary
Cary, North Carolina, United States
- Pmg Research of Charlotte
Charlotte, North Carolina, United States
- Pmg Research of Raleigh
Raleigh, North Carolina, United States
- Pmg Research of Wilmington
Wilmington, North Carolina, United States
- Midwest Clinical Research Center
Dayton, Ohio, United States
- Pmg Research of Bristol
Bristol, Tennessee, United States
- Noccr
Knoxville, Tennessee, United States
- Benchmark
Austin, Texas, United States
- Benchmark
Fort Worth, Texas, United States
- Benchmark
San Angelo, Texas, United States
- National Clinical Research
Richmond, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 12 Mar 2015
- Primary completion
- 13 Sept 2016
- Completion
- 1 Aug 2017
- Last update posted
- 26 Jan 2023
- Registered enrollment
- 1,039
- Registry id
- NCT02396381
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.